Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.
2.

Acute myeloid leukemia and the position of autologous stem cell transplantation.

Breems DA, Löwenberg B.

Semin Hematol. 2007 Oct;44(4):259-66. Review.

PMID:
17961725
3.

Treatment strategies for pediatric acute myeloid leukemia.

Absalon MJ, Smith FO.

Expert Opin Pharmacother. 2009 Jan;10(1):57-79. doi: 10.1517/14656560802627929 . Review.

PMID:
19236182
4.

[Current situation and perspective for treatment of acute myelogenous leukemia in adults].

Fukushima T, Ueda T.

Gan To Kagaku Ryoho. 1998 Feb;25(3):295-302. Review. Japanese.

PMID:
9492819
5.

Autologous bone marrow transplantation for leukemia.

Stuart RK.

Semin Oncol. 1993 Oct;20(5 Suppl 6):40-54. Review.

PMID:
8211215
6.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

7.

A systematic overview of chemotherapy effects in acute myeloid leukaemia.

Kimby E, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care..

Acta Oncol. 2001;40(2-3):231-52. Review.

PMID:
11441935
8.

Generalized linear mixed models for meta-analysis.

Platt RW, Leroux BG, Breslow N.

Stat Med. 1999 Mar 30;18(6):643-54. Review.

PMID:
10204195
9.

Response in acute myeloid leukemia.

Estey E.

Clin Adv Hematol Oncol. 2008 Feb;6(2):113-7. Review.

PMID:
18347562
10.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care..

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
12.
13.

Treatment of refractory and relapsed acute myelogenous leukemia.

Stanisic S, Kalaycio M.

Expert Rev Anticancer Ther. 2002 Jun;2(3):287-95. Review.

PMID:
12113052
14.

Third biannual report of the Cochrane Haematological Malignancies Group.

Kober T, Skoetz N, Trelle S, Bohlius J, Engert A; Cochrane Haematological Malignancies Group..

J Natl Cancer Inst. 2005 Aug 17;97(16):E2. Review. No abstract available.

15.

Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).

Copelan EA, Biggs JC, Szer J, Thompson JM, Crilley P, Brodsky I, Klein JL, Kapoor N, Harman GS, Avalos BR.

Semin Oncol. 1993 Aug;20(4 Suppl 4):33-8; quiz 39. Review.

PMID:
8342074
Items per page

Supplemental Content

Support Center